Biotechnology and pharmaceutical patents law and practice
Biopharma intellectual property that is patentable subject matter -- The novelty requirement -- Nonobviousness -- Formal standards of patentability for biopharma inventions -- Restriction and double patenting -- Inequitable conduct: what it is and how to avoid it -- How to write a biopharma patent a...
Gespeichert in:
| 1. Verfasser: | |
|---|---|
| Weitere Verfasser: | , |
| Format: | UnknownFormat |
| Sprache: | eng |
| Veröffentlicht: |
New York
Aspen Publishers
c2008 -
|
| Schlagworte: | |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Tag hinzufügen | Zusammenfassung: | Biopharma intellectual property that is patentable subject matter -- The novelty requirement -- Nonobviousness -- Formal standards of patentability for biopharma inventions -- Restriction and double patenting -- Inequitable conduct: what it is and how to avoid it -- How to write a biopharma patent application -- How and when to file biopharma patent applications -- Identifying the inventors -- Protecting ip rights of nonprofit institutions -- How to prosecute a biopharma patent application -- Post-grant procedures -- Extending the life of a biopharma patent -- Licensing biopharma patents -- Patent infringement -- Statutory infringement of pharmaceutical patents under the Hatch-Waxman Act -- Approval of biologics and the prospect of follow-on biologics -- Assertion of patent infringement in the international trade commission -- Regulatory exclusivities for pharmaceutical products -- Trademark issues relating to pharmaceuticals -- Protection of ip rights by trade secrets -- How to obtain biopharma patents in Canada, China, the European Union, India, and Japan -- Biopharma patent-related regulatory approval provisions in Canada, China, the European Union, India, and Japan -- How to enforce biopharma patents in Canada, China, the European Union -- India, and Japan |
|---|---|
| Beschreibung: | Losebl.-Ausg. |
| ISBN: | 9780735562660 978-0-7355-6266-0 |